4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-055073
Chief Scientific Officer sold 22,200 shares at an average $51.86 ($1,151,338)
- Chief Scientific Officer acquired 22,200 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-10-14 | Option exercise | +11,100 | $6.32 | $70,152 | 11,779 | D: show line 1 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-10-14 | Sale | −7,620 | $51.87 | $395,249 | 4,159 | D: show line 2 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-10-14 | Sale | −3,480 | $52.84 | $183,883 | 679 | D: show line 3 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-10-15 | Option exercise | +11,100 | $6.32 | $70,152 | 11,779 | D: show line 4 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-10-15 | Sale | −11,100 | $51.55 | $572,205 | 679 | D: show line 5 in the form |
| Open-market sales · 22,200 sh · avg $51.86 · $1,151,338 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-10-14 | Option exercise · Stock Option (Right to Buy) | −11,100 | 289,200 | D: show line 6 in the form | ||
| ROBINS HARLAN S Chief Scientific Officer | 2020-10-15 | Option exercise · Stock Option (Right to Buy) | −11,100 | 278,100 | D: show line 7 in the form |
Loading xslF345X03/doc4.xml…